• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    American J Hematol - 2022 - ...
    Size:
    554.6Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Allsup, D.
    Craig, Z.
    Cairns, D.
    Howard, D.
    Hockaday, A.
    Bloor, A.
    Soe, Z.
    Pepper, C.
    Gattei, V.
    Zucchetto, A.
    Robbe, P.
    Clifford, R.
    Schuh, A.
    Munir, T.
    Rawstron, A.
    Hillmen, P.
    Show allShow less
    Affiliation
    Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. Clinical Trials Research Unit, University of Leeds, Leeds, UK. The Christie NHS Foundation Trust, Manchester, UK. St James Institute of Oncology, Leeds, UK. Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy. Laboratory for Transcriptome Technology, RIKEN Centre for Integrative Medical Sciences, Yokohama, Japan. Department of Haematology, University Hospital Limerick, Limerick, Ireland. Department of Oncology, University of Oxford, Oxford, UK. Haematological Malignancy Diagnostic Service, St James Hospital, Leeds, UK. Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
    Issue Date
    2022
    
    Metadata
    Show full item record
    Citation
    Allsup DJ, Craig Z, Cairns D, Howard D, Hockaday A, Bloor A, et al. Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. American Journal of Hematology. Wiley; 2022.
    Journal
    American Journal of Hematology
    URI
    http://hdl.handle.net/10541/625070
    DOI
    10.1002/ajh.26483
    PubMed ID
    35108412
    Additional Links
    https://dx.doi.org/10.1002/ajh.26483
    Type
    Other
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1002/ajh.26483
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
    • Authors: Howard DR, Munir T, McParland L, Rawstron AC, Chalmers A, Gregory WM, O'Dwyer JL, Smith A, Longo R, Varghese A, Smith A, Hillmen P
    • Issue date: 2017 May
    • Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
    • Authors: Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, Hensel M, Hopfinger G, Hess G, von Grünhagen U, Bergmann M, Catalano J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jäger U, Cazin B, Trneny M, Westermann A, Wendtner CM, Eichhorst BF, Staib P, Bühler A, Winkler D, Zenz T, Böttcher S, Ritgen M, Mendila M, Kneba M, Döhner H, Stilgenbauer S, International Group of Investigators, German Chronic Lymphocytic Leukaemia Study Group
    • Issue date: 2010 Oct 2
    • Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study.
    • Authors: Herling CD, Coombes KR, Benner A, Bloehdorn J, Barron LL, Abrams ZB, Majewski T, Bondaruk JE, Bahlo J, Fischer K, Hallek M, Stilgenbauer S, Czerniak BA, Oakes CC, Ferrajoli A, Keating MJ, Abruzzo LV
    • Issue date: 2019 Nov
    • First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.
    • Authors: Eichhorst B, Fink AM, Bahlo J, Busch R, Kovacs G, Maurer C, Lange E, Köppler H, Kiehl M, Sökler M, Schlag R, Vehling-Kaiser U, Köchling G, Plöger C, Gregor M, Plesner T, Trneny M, Fischer K, Döhner H, Kneba M, Wendtner CM, Klapper W, Kreuzer KA, Stilgenbauer S, Böttcher S, Hallek M, international group of investigators, German CLL Study Group (GCLLSG)
    • Issue date: 2016 Jul
    • Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience.
    • Authors: Herishanu Y, Goldschmidt N, Bairey O, Ruchlemer R, Fineman R, Rahimi-Levene N, Shvidel L, Tadmor T, Ariel A, Braester A, Shapiro M, Joffe E, Polliack A, Israeli CLL Study Group
    • Issue date: 2015 May
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.